Evidence map›Paper›PMID 2153155›Full record

ArticleThe Journal of clinical investigation1990

A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.

S J Usala, G E Tennyson, A E Bale, R W Lash, N Gesundheit, F E Wondisford, D Accili, P Hauser, B D Weintraub

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1990. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
18.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 183 citations in OpenAlex.

  1. Article
  2. Review
  3. The actions of thyroid hormone signaling in the nucleus.Molecular and cellular endocrinology · 2017
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Complete activation of thyroid hormone receptor β by T3 is essential for normal cochlear function and morphology in mice.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2011
    Article
  11. Approach to the patient with resistance to thyroid hormone and pregnancy.The Journal of clinical endocrinology and metabolism · 2010
    Article
  12. A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  13. Thyroid hormone receptor beta gene mutation (P453A) in a family producing resistance to thyroid hormone.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2009
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

S J UsalaMolecular Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892.
G E Tennyson
A E Bale
R W Lash
N Gesundheit
F E Wondisford
D Accili
P Hauser
B D Weintraub
East Carolina University · USNational Institute of Diabetes and Digestive and Kidney Diseases · USDiabetes Australia · AUYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generalized thyroid hormone resistance (GTHR) is a disorder of thyroid hormone action that we have previously shown to be tightly linked to one of the two thyroid hormone receptor genes, c-erbA beta, in a single kindred, A. We now show that in two other kindreds, B and D, with differing phenotypes, there is also linkage between c-erbA beta and GTHR. The combined maximum logarithm of the odds score for all three kindreds at a recombination fraction of 0 was 5.77. In vivo studies had shown a triiodothyronine (T3)-binding affinity abnormality in nuclear receptors of kindred A, and we therefore investigated the defect in c-erbA beta in this kindred by sequencing a major portion of the T3-binding domain in the 3'-region of fibroblast c-erbA beta cDNA and leukocyte c-erbA beta genomic DNA. A base substitution, cytosine to adenine, was found at cDNA position 1643 which altered the proline codon at position 448 to a histidine. By allelic-specific hybridization, this base substitution was found in only one allele of seven affected members, and not found in 10 unaffected members of kindred A, as expected for a dominant disease. Also, this altered base was not found in kindreds B or D, or in 92 random c-erbA beta alleles. These results and the fact that the mutation is predicted to alter the secondary structure of the crucial T3-binding domain of the c-erbA beta receptor suggest this mutation is an excellent candidate for the genetic cause of GTHR in kindred A. Different mutations in the c-erbA beta gene are likely responsible for the variant phenotypes of thyroid hormone resistance in kindreds B and D.

Indexed as

MutationAllelesBase SequenceDNADrug ResistanceFemaleGenetic LinkageHumansMaleMolecular Sequence DataNucleic Acid HybridizationPedigreePhenotypeProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-OncogenesDNAProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptors, Thyroid HormoneThyroid Hormones

Identifiers

PMID2153155
PMCPMC296391
OpenAlexW2024421544

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.